Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Duchenne Muscular Dystrophy Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Duchenne Muscular Dystrophy Treatment Market Perspective (2018-2033)
2.2 Duchenne Muscular Dystrophy Treatment Growth Trends by Region
2.2.1 Global Duchenne Muscular Dystrophy Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Duchenne Muscular Dystrophy Treatment Historic Market Size by Region (2018-2023)
2.2.3 Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Region (2024-2033)
2.3 Duchenne Muscular Dystrophy Treatment Market Dynamics
2.3.1 Duchenne Muscular Dystrophy Treatment Industry Trends
2.3.2 Duchenne Muscular Dystrophy Treatment Market Drivers
2.3.3 Duchenne Muscular Dystrophy Treatment Market Challenges
2.3.4 Duchenne Muscular Dystrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Duchenne Muscular Dystrophy Treatment Players by Revenue
3.1.1 Global Top Duchenne Muscular Dystrophy Treatment Players by Revenue (2018-2023)
3.1.2 Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Duchenne Muscular Dystrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Duchenne Muscular Dystrophy Treatment Revenue
3.4 Global Duchenne Muscular Dystrophy Treatment Market Concentration Ratio
3.4.1 Global Duchenne Muscular Dystrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Duchenne Muscular Dystrophy Treatment Revenue in 2022
3.5 Duchenne Muscular Dystrophy Treatment Key Players Head office and Area Served
3.6 Key Players Duchenne Muscular Dystrophy Treatment Product Solution and Service
3.7 Date of Enter into Duchenne Muscular Dystrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Duchenne Muscular Dystrophy Treatment Breakdown Data by Type
4.1 Global Duchenne Muscular Dystrophy Treatment Historic Market Size by Type (2018-2023)
4.2 Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Type (2024-2033)
5 Duchenne Muscular Dystrophy Treatment Breakdown Data by Application
5.1 Global Duchenne Muscular Dystrophy Treatment Historic Market Size by Application (2018-2023)
5.2 Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Duchenne Muscular Dystrophy Treatment Market Size (2018-2033)
6.2 North America Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023)
6.4 North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Duchenne Muscular Dystrophy Treatment Market Size (2018-2033)
7.2 Europe Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023)
7.4 Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size (2018-2033)
8.2 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Duchenne Muscular Dystrophy Treatment Market Size (2018-2033)
9.2 Latin America Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023)
9.4 Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size (2018-2033)
10.2 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ITALFARMACO SpA
11.1.1 ITALFARMACO SpA Company Detail
11.1.2 ITALFARMACO SpA Business Overview
11.1.3 ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Introduction
11.1.4 ITALFARMACO SpA Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
11.1.5 ITALFARMACO SpA Recent Development
11.2 FibroGen, Inc.
11.2.1 FibroGen, Inc. Company Detail
11.2.2 FibroGen, Inc. Business Overview
11.2.3 FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Introduction
11.2.4 FibroGen, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
11.2.5 FibroGen, Inc. Recent Development
11.3 Summit Therapeuticsplc
11.3.1 Summit Therapeuticsplc Company Detail
11.3.2 Summit Therapeuticsplc Business Overview
11.3.3 Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Introduction
11.3.4 Summit Therapeuticsplc Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
11.3.5 Summit Therapeuticsplc Recent Development
11.4 PTC Therapeutics
11.4.1 PTC Therapeutics Company Detail
11.4.2 PTC Therapeutics Business Overview
11.4.3 PTC Therapeutics Duchenne Muscular Dystrophy Treatment Introduction
11.4.4 PTC Therapeutics Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
11.4.5 PTC Therapeutics Recent Development
11.5 Santhera Pharmaceuticals
11.5.1 Santhera Pharmaceuticals Company Detail
11.5.2 Santhera Pharmaceuticals Business Overview
11.5.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Introduction
11.5.4 Santhera Pharmaceuticals Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
11.5.5 Santhera Pharmaceuticals Recent Development
11.6 Sarepta Therapeutics, Inc.
11.6.1 Sarepta Therapeutics, Inc. Company Detail
11.6.2 Sarepta Therapeutics, Inc. Business Overview
11.6.3 Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Introduction
11.6.4 Sarepta Therapeutics, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
11.6.5 Sarepta Therapeutics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of NSAIDs
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Others
Table 5. Global Duchenne Muscular Dystrophy Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Duchenne Muscular Dystrophy Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Duchenne Muscular Dystrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Duchenne Muscular Dystrophy Treatment Market Share by Region (2018-2023)
Table 9. Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Duchenne Muscular Dystrophy Treatment Market Share by Region (2024-2033)
Table 11. Duchenne Muscular Dystrophy Treatment Market Trends
Table 12. Duchenne Muscular Dystrophy Treatment Market Drivers
Table 13. Duchenne Muscular Dystrophy Treatment Market Challenges
Table 14. Duchenne Muscular Dystrophy Treatment Market Restraints
Table 15. Global Duchenne Muscular Dystrophy Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Duchenne Muscular Dystrophy Treatment Market Share by Players (2018-2023)
Table 17. Global Top Duchenne Muscular Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy Treatment as of 2022)
Table 18. Ranking of Global Top Duchenne Muscular Dystrophy Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Duchenne Muscular Dystrophy Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Duchenne Muscular Dystrophy Treatment Product Solution and Service
Table 22. Date of Enter into Duchenne Muscular Dystrophy Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Duchenne Muscular Dystrophy Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Duchenne Muscular Dystrophy Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Duchenne Muscular Dystrophy Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Duchenne Muscular Dystrophy Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. ITALFARMACO SpA Company Detail
Table 48. ITALFARMACO SpA Business Overview
Table 49. ITALFARMACO SpA Duchenne Muscular Dystrophy Treatment Product
Table 50. ITALFARMACO SpA Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023) & (US$ Million)
Table 51. ITALFARMACO SpA Recent Development
Table 52. FibroGen, Inc. Company Detail
Table 53. FibroGen, Inc. Business Overview
Table 54. FibroGen, Inc. Duchenne Muscular Dystrophy Treatment Product
Table 55. FibroGen, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023) & (US$ Million)
Table 56. FibroGen, Inc. Recent Development
Table 57. Summit Therapeuticsplc Company Detail
Table 58. Summit Therapeuticsplc Business Overview
Table 59. Summit Therapeuticsplc Duchenne Muscular Dystrophy Treatment Product
Table 60. Summit Therapeuticsplc Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023) & (US$ Million)
Table 61. Summit Therapeuticsplc Recent Development
Table 62. PTC Therapeutics Company Detail
Table 63. PTC Therapeutics Business Overview
Table 64. PTC Therapeutics Duchenne Muscular Dystrophy Treatment Product
Table 65. PTC Therapeutics Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023) & (US$ Million)
Table 66. PTC Therapeutics Recent Development
Table 67. Santhera Pharmaceuticals Company Detail
Table 68. Santhera Pharmaceuticals Business Overview
Table 69. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Treatment Product
Table 70. Santhera Pharmaceuticals Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023) & (US$ Million)
Table 71. Santhera Pharmaceuticals Recent Development
Table 72. Sarepta Therapeutics, Inc. Company Detail
Table 73. Sarepta Therapeutics, Inc. Business Overview
Table 74. Sarepta Therapeutics, Inc. Duchenne Muscular Dystrophy Treatment Product
Table 75. Sarepta Therapeutics, Inc. Revenue in Duchenne Muscular Dystrophy Treatment Business (2018-2023) & (US$ Million)
Table 76. Sarepta Therapeutics, Inc. Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Duchenne Muscular Dystrophy Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Duchenne Muscular Dystrophy Treatment Market Share by Type: 2022 VS 2033
Figure 3. NSAIDs Features
Figure 4. Corticosteroids Features
Figure 5. Others Features
Figure 6. Global Duchenne Muscular Dystrophy Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Duchenne Muscular Dystrophy Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Duchenne Muscular Dystrophy Treatment Report Years Considered
Figure 12. Global Duchenne Muscular Dystrophy Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Duchenne Muscular Dystrophy Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Duchenne Muscular Dystrophy Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Duchenne Muscular Dystrophy Treatment Market Share by Players in 2022
Figure 16. Global Top Duchenne Muscular Dystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Duchenne Muscular Dystrophy Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Duchenne Muscular Dystrophy Treatment Revenue in 2022
Figure 18. North America Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Duchenne Muscular Dystrophy Treatment Market Share by Country (2018-2033)
Figure 20. United States Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Duchenne Muscular Dystrophy Treatment Market Share by Country (2018-2033)
Figure 24. Germany Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Duchenne Muscular Dystrophy Treatment Market Share by Region (2018-2033)
Figure 32. China Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Duchenne Muscular Dystrophy Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Duchenne Muscular Dystrophy Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Duchenne Muscular Dystrophy Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. ITALFARMACO SpA Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
Figure 47. FibroGen, Inc. Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
Figure 48. Summit Therapeuticsplc Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
Figure 49. PTC Therapeutics Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
Figure 50. Santhera Pharmaceuticals Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
Figure 51. Sarepta Therapeutics, Inc. Revenue Growth Rate in Duchenne Muscular Dystrophy Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed